The role of beta carotene (20mg/kg) and hesperidin (100mg/kg) 
INTRODUCTION
Imidacloprid (IM) is a member of a group of insecticides called neonicotinoids. The extensive use of insecticides has been reviewed in recent years due to their stability in the environment and their accumulation in the living tissues of organisms. Imidacloprid is extensively used in agriculture for control of the sucking insects and also used as a foliar treatment for soil and for seed dressing . IM evokes hepatic oxidative stress as confirmed by the increase of lipid peroxidation and a decrease of reduced glutathione (Ahmed and Nasr, 2015). It was found that the toxicity of imidacloprid can originate from free radicals production by the cell which causes an oxidative stress and tissue damages (El-Gendy et al., 2010). These damages modified macromolecules such as nucleic acids, lipids, and proteins, which result in functional changes of the target cell (Stephan et al., 1997).
Antioxidants can eliminate free radicals and other reactive oxygen and nitrogen species, and these reactive species contribute to most chronic diseases. The natural antioxidants in foods may induce antioxidant defense mechanisms (Kensler et al., 2007). Phytochemicals, which are found in fruits, vegetables, and plant-derived beverages, may act as cytoprotective agents in many organs ). The present study aims to examine the antioxidant activity of beta carotene and hesperidin (separately or in combination) against imidacloprid-induced hepatotoxicity and oxidative stress.
MATERIAL AND METHODS

Chemicals:
Imidacloprid of 96 % purity produced by the Bayer (Germany) was used in the present experiments. Beta Carotene (BC) was obtained from El-Goumhouria Co. for Trading Medicine, Cairo, Egypt. Hesperidin was obtained from Sigma, USA.
Animals:
Fifty-four adult male albino rats (Rattus norvegicus), weighing 140 -160 g. were used in the present study. The rats were purchased from the animal house, National Research Centre, Egypt. (Dokki, Giza, Egypt). They were kept for one week for acclimatization before the experiment. They were housed in standard polypropylene cages and kept under thermostatically controlled room of 12-h light/dark cycle. They were maintained on standard pellet diet with free access to water.
Ethics statement
This experiment was carried out in according to the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH publication No. 85-23, revised 1996) and under regulations of Animal Care and Use of National Research Centre in Egypt. All sampling was performed under light anesthesia with ether.
Experimental design:
Rats were randomly divided into the following groups:
Group I Considered as normal control (n=6 rats).
Group II
A-Animal received a daily low dose of imidacloprid (45 mg/kg b.w., 1/10 LD50) orally for 30 days (n= 6 rats).
B-Animal received a daily high dose of imidacloprid (90 mg/kg b.w., 1/5 LD50) orally for 30 days (n= 6 rats).
Group III
A-The rats were treated daily with a low dose of imidacloprid (45 mg/kg b.w.) and beta carotene at a dose level of 20 mg/kg b.w. (Cui et al., 2012) orally for 30 days (n= 6 rats).
B-The animals received a daily high dose of imidacloprid (90 mg/kg b.w.) and beta carotene (20 mg/kg b.w.) orally for 30 days (n= 6 rats).
Group IV
A-The rats received a daily low dose of imidacloprid (45 mg/kg b.w.) and hesperidin at the dose of 100 mg/kg b.w. (Kumar et al., 2017) orally for 30 days (n= 6 rats).
B-Each animal received a daily high dose of imidacloprid (90 mg/kg b.w.) and hesperidin (100 mg/kg b.w.) orally for 30 days (n= 6 rats).
Group V
A-Each animal received a low dose of imidacloprid orally after administration of beta carotene and hesperidin in combination daily for 30 days (n= 6 rats).
B-Each animal received a daily high dose of imidacloprid orally after administration of beta carotene and hesperidin in combination for 30 days (n= 6 rats).
Both IM and HSP were dissolved in water, while βC was dissolved in corn oil.
Determination of imidacloprid LD50 in rats
The oral LD 
Samples collection:
At the end of the experiment, blood was withdrawn from retro-orbital plexus of the eye and collected in glass centrifuge tubes and allows it to clot at room temperature for thirty minutes. Blood samples were centrifuged at 4000 rpm, for 10 min, and serum was separated into eppendorph tubes and stored at -20 C till used for biochemical analysis. The liver were removed and fixed in 10 % formol saline for histological examination.
Biochemical analysis
Total protein, albumin, AST, ALT, ALP, GGT, α-FP ,total bilirubin, total cholesterol, and triglycerides were determined in serum by chemistry analyzer, Beckman Coulter-Model AU 480, Full automatic, Japan, using Roche kits. Moreover, MDA, SOD, catalase, GSH, and N.O were determined colorimetrically in liver tissues (Photometer-Model 5010) using commercial kits produced by Biodiagnostic, Egypt. ELISA technique was carried out for the assay of tumor necrosis factor-alpha (R and D Systems, USA).
Histological evaluation:
Slices of liver tissue were fixed in 10 % formol saline, and processed for preparation of paraffin blocks. Sections of 5-7 µ in thickness were cut and stained with Hematoxylin & Eosin (H&E) stain.
Statistical analysis:
The data were analyzed using the one-way analysis of variance (ANOVA) followed by Fisher's least significant difference (LSD) analysis to compare various groups with each other. Results were expressed as a mean ± standard error (SE).
RESULTS:
Biochemical parameters:
It was observed that hepatic catalase, GSH, and SOD levels of rats treated with IM decreased significantly (P≤0.05) in comparison with control (Table 1) . On the other hand, hepatic MDA, N.O and TNF-α concentrations of IM group elevated significantly. Although, hepatic SOD, CAT, and GSH of BC+IM or H+IM groups lowered significantly as compared with control, their values were higher significantly than those of IM group. Both beta carotene and hesperidin reduced the effects of IM on hepatic oxidative stress parameters.
The results demonstrated a significant increase of AST, ALT, ALP, GGT and total bilirubin (Table2) in all treated groups. The values of liver enzymes and bilirubin levels of beta carotene + IM or hesperidin + IM groups were significantly lower than those of IM group. Similar results were obtained in the case of alpha-fetoprotein.
The total protein and albumin levels in serum of IM group showed a significant decrease (P≤0.05), while total cholesterol and triglycerides levels exhibited a significant increase (P≤0.05) as compared with control (Table 3) . Both beta carotene and hesperidin alleviated the effects of IM on previous parameters.
Histological results of the liver:
The liver of control rats revealed the normal characteristic architecture of hepatic lobules and central vein (Fig. 1A) . In the case of liver sections treated with 1/5 LD50 of imidacloprid insecticide showing dilated, congested, edematous, vacuolated portal vein with infiltration of leukocytes and a fibrosis around the bile duct. Dilated and congested blood sinusoid, sings of degeneration in the form of karyolysis, karyorrhexis and foci of necrosis were seen (Figs. 1B, C, D) .
The microscopic examination of liver tissue of a rat subjected to 1/10 LD50 of imidacloprid insecticide showing hepatocytes with homogenous cytoplasm, congested of portal vein and thickening of the wall and vacuolar degeneration. Dilated blood sinusoids, foci of necrosis and karyolysis (Figs. 2A, B) .
Concerning rats treated with 1/5 LD50 with imidacloprid along with beta carotene showing normal histological structure of hepatic lobules but mild dilated of blood sinusoid and vacuolar degeneration could be observed (Fig. 2C) . The liver of rats treated with 1/10 LD50 with imidacloprid along with beta carotene showing a normal histological structure of hepatic lobules but mild dilated and congestion of blood sinusoid and minute vacuolar degeneration could be observed (Fig. 2D ).
Microscopic examination of liver tissue from of rats treated with 1/5 LD50 with imidacloprid along with hesperidin showing vacuolar degeneration, dilated blood sinusoid and dilated and congested blood vessel (Fig.3A) . The hepatocyte of a rat treated with 1/10 LD50 of imidacloprid insecticide along with hesperidin showing most of hepatocyte appeared normal and few appeared necrotic and congested blood vessel (Fig. 3B ).
In the case of the liver of a rat treated with 1/5 LD50 of imidacloprid insecticide along with beta carotene and hesperidin showing most of hepatocyte appeared normal but necrosis of some hepatocyte (thickening in the wall of portal vessel, hypertrophied of kupffer cells (Fig. 3C) . Concerning rats treated with 1/10 LD50 with imidacloprid along with hesperidin and beta carotene showing most of the hepatocyte appeared normal but minute vacuolar degeneration still present (Fig. 3D) . 
DISCUSSION
Exposure to imidacloprid has been associated with hepatotoxicity and tissue damage (Arfat et al., 2014) through several oxidative mechanisms and lipid peroxidation that modulate antioxidants or free radical scavenging enzyme systems (El-Gendy et al., 2010). Oxidative damage may result from decreased clearance of ROS by scavenging mechanisms. The cells are provided with a number of mechanisms to protect themselves from the toxic effects of oxidative stress. GSH is highly abundant in all cell compartments and is the major soluble antioxidant. GSH shows its antioxidant effects in several ways. It detoxifies hydrogen peroxide and lipid peroxides. GSH donates its electron to H2O2 to reduce it into H2O and O2. GSSG is again reduced into GSH by GSH reductase that uses NAD(P)H as the electron donor (Masella et al., 2005) . The SOD eliminates superoxide by converting it into H2O2 which is rapidly transformed to water by CAT (Mahdi, 2002) . Our results showed that imidacloprid motivates oxidative stress as evidenced by an increase of hepatic MDA, marker of lipid peroxidation and a decrease of GSH, CAT and SOD levels. The decreased activity of CAT, SOD (antioxidant enzymes) and GSH along with an increase of lipid peroxide levels could likely be associated with oxidative stress and decreased antioxidant defense potential. The decreased rate of glutathione synthesis has been found in many diseases such as fibrosis and a variety of hepatic disorders. Decreased GSH synthesis occurs as a result of decreased expression of the synthetic enzymes )Lu, 2013). Since GSH is involved in the removal of reactive oxygen species (ROS) from the cells, a decreased production of GSH will lead to an accumulation of ROS in the cell that cause DNA, protein and membrane damage (Anderson, 1998) . The hepatic N.O elevated significantly in the present investigation due to IM treatment. Despite nitric oxide has important physiological functions, N.O is also a well-known toxic agent (Grisham et al., 1999) . Overproduction of N.O in the liver has been involved as an important incident in hepatic inflammation and injury (Gardner et al., 1998).
Treatment with β-carotene or hesperidin to IM given rats lowered hepatic MDA and increased hepatic GSH, CAT, and SOD levels as compared to IM group. This may be referred to antioxidant property of β-carotene or hesperidin, which scavenges the free radical and thereby, maintain the levels of antioxidants (GSH, CAT, SOD).The antioxidant mechanism of β-carotene and hesperidin has been suggested to occur via quenching of singlet oxygen, free radical scavenging and chain breaking during lipid peroxidation (Galano et al., 2010 and Balakrishnan & Menon, 2007). β-carotene Protects of cellular membranes and lipoproteins against oxidative damage (Ciccone et al., 2013). Carotenoids quench singlet oxygen primarily by a physical mechanism, in which excess energy of single oxygen is transferred to carotenoids and then they return into the ground state, as a result carotenoids offer to protect against further oxygen radical and lipid peroxidation (Mc Nulty et al., 2008) . Both β-carotene and hesperidin can combat oxidative stress. β-carotene reduced oxidative stress evoked by acetaminophen and restored the activity of hepatic antioxidant defense system (Morakinyo et al., 2012) . Hesperidin attenuates cyclophosphamide induced depletion of cardiac antioxidant enzymes and elevation of MDA level (Kumar et al., 2011) .
The present results demonstrated a significant increase in serum liver enzymes, bilirubin and alpha-fetoprotein. Some studies showed that AST elevation was significantly associated with the rise of AFP level (Chen et  al., 2008 and Hu et al., 2004) . The liver damage and change of membrane characteristics led to the leakage of hepatic enzymes and therefore elevation of its level in the plasma. The increase in liver enzymes may indicate hepatocytes necrosis (Gressner et al.,  2007) . The histopathological changes in the liver induced by IM affirm the previous results as manifested by fibrosis around the bile duct, vacuolar degeneration, dilated congested blood sinusoid, and necrosis of some hepatocytes. The results of imidacloprid group are dose dependent. The histopathological changes can be attributed to increasing of hepatic MDA level, a marker of lipid peroxidation or TNF-α. Lipid peroxidation is a process under which oxidants such as free radicals attack lipids, particularly polyunsaturated fatty acids that involve hydrogen abstraction from a carbon, with oxygen insertion resulting in lipid peroxyl radicals and hydroperoxides as described previously (Szabó et al., 2007) . The lipid free radical interactions produce peroxides, which are themselves unstable and reactive and an autocatalytic chain reaction called propagation which can result in an extensive membrane, organellar, and cellular damage ( There was an association between alphafetoprotein levels and increased risk for metabolic syndrome including a rise of cholesterol and triglycerides levels (Chen et al., 2016). The elevation of serum triglycerides can be referred to a suppression of the lipase enzyme activity (Goldberg et al., 1982) or to lipolysis stimulation by TNF-α (Sethi et al.,  2000) . It was found that TNF-α increases plasma TG by increasing the concentration of free fatty acids (Feingold et al., 1994) , the substrate for TG synthesis. Both beta-carotene and hesperidin inhibit the elevation of cholesterol and triglycerides induced by IM in rats. It was found that Dietary supplementation with beta-carotene decreased serum total cholesterol and hepatic total lipid and cholesterol contents .These changes were accompanied by an increase in the total lipid and cholesterol contents excreted in the feces (Silva et al., 2013) . The previous author suggested that beta-carotene administration may decrease cholesterol absorption in the intestine and increase cholesterol excretion into the feces without a direct effect on the expression of cholesterol metabolism genes. Bok et al. (1999) concluded that hesperidin significantly lowered the plasma and hepatic levels of cholesterol and TG by inhibiting HMG-CoA reductase and acyl CoA: cholesterol acyltransferase in rats.
A synergistic effect of a combination of hesperidin, a flavonoid, and Lycopene, a carotenoid has been reported due to their antioxidant activities (Jain and Katti, 2015). In the present study, the synergetic potential of the combination of β-carotene and hesperidin appears beneficial in the mitigation of hepatotoxicity induced by IM.
In conclusion, chronic imidacloprid treatment gives rise to oxidative stress and inflammation by modifying antioxidant systems and motivating pro-inflammatory cytokine production in the hepatic cells. Both β-carotene, and hesperidin reduced the deleterious effects of imidacloprid on liver via allevation of oxidative stress, reduction of inflammatory cytokine level and maintaining antioxidant enzymes. The present study proposed a synergistic effect of a combination of β-carotene and hesperidin. 
